BRCA1 promoter methylation status does not predict response to tamoxifen in sporadic breast cancer patients.
BRCA1 promoter methylation status does not predict response to tamoxifen in sporadic breast cancer patients. Breast Cancer Res Treat. 2012 Aug; 135(1):135-43.